An audit of postpartum thromboprophylaxis practices and outcomes following caesarean delivery
C. Simard a),b); R. Cantara c); M.P. Bastrash d); C. Antinora e); M. Plourde e); M.J. Trahan f); A. Do g); M. Koolian a); E. Suarthana f); K. Wou f); I. Malhamé h),i).
a) Department of Medicine, Jewish General Hospital, Montreal, Canada
b) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
c) Faculty of Medicine, Université de Montréal, Montreal, Canada
d) Department of Obstetrics and Gynecology, LaSalle Hospital and Jewish General Hospital, Montreal, Canada
e) Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada
f) Department of Obstetrics and Gynecology, McGill University Health Centre, Montreal, Canada
g) Department of Pharmacy, McGill University Health Centre, Montreal, Canada
h) Department of Medicine, McGill University Health Centre, Montreal, Canada
i) Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada
Highlights
• Post caesarean delivery thromboprophylaxis practices vary, due to limited evidence.
• We studied real-world data on postpartum thromboprophylaxis use.
• Major bleeding events occurred before thromboprophylaxis was administered.
• Clinical equipoise persists on anticoagulation risks and benefits in this population.